US legal appeal rejected in win for Novo Nordisk
A US court has rejected an appeal attempting to overturn a ruling that Novo Nordisk’s type 2 diabetes drug, Victoza, does not cause cancer.
by christian bundgaard, translated by catherine brett
The 9th US Circuit Court of Appeals voted unanimously on Monday to reject an attempt to reopen a legal case against Novo Nordisk, reports Reuters. The case concerned its type 2 diabetes drug Victoza, which the plaintiff claimed could cause pancreatic cancer.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
